CD70 expression
|
Uterine Corpus Leiomyosarcoma
|
CD70 expression
|
Uterine Corpus Leiomyosarcoma
|
ARX305 Sensitive: C3 – Early Trials
|
ARX305 Sensitive: C3 – Early Trials
|
CD70 expression
|
Cutaneous T-cell Lymphoma
|
CD70 expression
|
Cutaneous T-cell Lymphoma
|
ARGX-110 Sensitive: C3 – Early Trials
|
ARGX-110 Sensitive: C3 – Early Trials
|
CD70 expression
|
AML
|
CD70 expression
|
AML
|
ALLO-316 Sensitive: D – Preclinical
|
ALLO-316 Sensitive: D – Preclinical
|
CD70 expression
|
AML
|
CD70 expression
|
AML
|
venetoclax + ARGX-110 Sensitive: D – Preclinical
|
venetoclax + ARGX-110 Sensitive: D – Preclinical
|